Concepedia

Jonathan L. Ditta

JL

Statistics

Publications

13

Citations

525

H-Index

13

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jonathan L. Ditta is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2000–2022

13

Publications

13

2-Aryl-2,2-difluoroacetamide FKBP12 Ligands:  Synthesis and X-ray Structural Studies

Gene M. Dubowchik, Vivekananda M. Vrudhula, Bireshwar Dasgupta et al. · Organic Letters · 2001 · 104 citations

, , +11

A Strategy to Minimize Reactive Metabolite Formation: Discovery of (<i>S</i>)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist

Richard A. Hartz, Vijay T. Ahuja, Xiaoliang Zhuo et al. · Journal of Medicinal Chemistry · 2009 · 54 citations · Full text

, , +17

High-Throughput Fluorescence Polarization Method for Identification of FKBP12 Ligands

Sagarika Bollini, John J. Herbst, G.T. Gaughan et al. · SLAS DISCOVERY · 2002 · 49 citations · Full text

, , +15

Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay

Gene M. Dubowchik, Jonathan L. Ditta, John J. Herbst et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 43 citations · Full text

, , +12

In Vitro Intrinsic Clearance-Based Optimization of<i>N</i><sup>3</sup>-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists

Richard A. Hartz, Vijay T. Ahuja, Maria Rafalski et al. · Journal of Medicinal Chemistry · 2009 · 38 citations · Full text

, , +16

1–5 of 13